|
|
ANSTO Publications Online >
Browsing by Author Katsifis, A
Showing results 1 to 16 of 16
| Issue Date | Title | Author(s) | | 1-Dec-2010 | Activation of signal pathways and the resistance to anti-EGFR treatment in colorectal cancer. | Chen, JZ; Huang, XF; Katsifis, A |
| 12-May-2008 | Alternative method for Cu-64 radioisotope production. | Le, VS; Howse, J; Zaw, M; Pellegrini, P; Katsifis, A; Greguric, I; Weiner, R |
| 1-Dec-2010 | Detection and quantification of remote microglial activation in rodent models of focal ischaemia using the TSPO radioligand CLINDE. | Arlicot, N; Petit, E; Katsifis, A; Toutain, J; Divoux, D; Bodard, S; Roussel, S; Guilloteau, D; Bernaudin, M; Chalon, S |
| 11-Oct-2010 | Development of [18F]-Flumazenil-PET for localisation of the epileptogenic zone in patients with medically refractory focal epilepsy. | Vivash, L; Gregoire, M; Dedeurwaerdere, S; Bouilleret, V; Roselt, P; Lau, EW; Ware, RE; Binns, D; Katsifis, A; Hicks, RJ; Myers, DE; O'Brien, TJ |
| 1-May-2011 | Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: a model of adverse antidepressant effects in human adolescents? | Karanges, E; Li, K; Motbey, C; Callaghan, P; Katsifis, A; McGregor, I |
| 10-Sep-2009 | Discovery of [F-18]N-(2-(Diethylamino)ethyl)-6-fluoronicotinamide: a melanoma positron emission tomography imaging radiotracer with high tumor to body contrast ratio and rapid renal clearance. | Greguric, I; Taylor, SR; Denoyer, D; Ballantyne, P; Berghofer, P; Roselt, P; Pham, TQ; Mattner, F; Bourdier, T; Neels, OC; Dorow, DS; Loc'h, C; Hicks, RJ; Katsifis, A |
| 1-Aug-2011 | Evaluation of [I-123]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation. | Mattner, F; Bandin, D L; Staykova, M; Berghofer, P; Gregoire, M-C; Ballantyne, P; Quinlivan, M; Fordham, S; Pham, T; Willenborg, D O; Katsifis, A |
| Mar-2010 | High-contrast PET of melanoma using F-18-MEL050, a selective probe for melanin with predominantly renal clearance. | Denoyer, D; Greguric, I; Roselt, P; Neels, OC; Aide, N; Taylor, SR; Katsifis, A; Dorow, DS; Hicks, RJ |
| 1-Jan-2011 | Improved detection of regional melanoma metastasis using 18F-6-Fluoro-N-[2-(Diethylamino)Ethyl] Pyridine-3-Carboxamide, a Melanin-specific PET probe, by perilesional administration. | Denoyer, D; Potdevin, T; Roselt, P; Neels, OC; Kirby, L; Greguric, I; Katsifis, A; Dorow, DS; Hicks, RJ |
| Jun-2009 | In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat. | Dedeurwaerdere, S; Gregoire, MC; Vivash, L; Roselt, P; Binns, D; Fookes, C; Greguric, I; Pham, T; Loc'h, C; Katsifis, A; Hicks, RJ; O'Brien, TJ; Myers, DE |
| 11-Oct-2010 | Metabolism of CLINDE, a peripheral benzodiazepine receptor SPECT ligand. | Peyronneau, M; Mattner, F; Howell, N; Jiang, C; Pelegrini, P; Greguric, I; Loch, C; Katsifis, A |
| 1-Aug-2008 | Radiochemical separation and quality assessment for the 68Zn target based 64Cu radioisotope production | Le, VS; Pellegrini, P; Katsifis, A; Howse, J; Greguric, I |
| Mar-2007 | Radiosynthesis of 2-[6-chloro-2-(4-iodophenyl)imidazo [1,2-a]pyridin-3-yl]-N-ethyl-N-[C-11]methyl-acetamide, [C-11]CLINME, a novel radioligand for imaging the peripheral benzodiazepine receptors with PET. | Thominiaux, CJ; Mattner, F; Greguric, I; Boutin, H; Chauveau, F; Kuhnast, B; Gregoire, MC; Loc'h, C; Valette, H; Bottlaender, M; Hantraye, P; Tavitian, B; Katsifis, A; Dolle, F |
| 1-Jan-2011 | Radiosynthesis of a novel PET fluoronicotinamide for melanoma tumour PET imaging [18F]MEL050. | Greguric, I; Taylor, S; Pham, T; Wyatt, N; Jiang, C D; Bourdier, T; Loc'h, C; Roselt, P; Neels, O C; Katsifis, A |
| Jan-2011 | Rapid solid-phase extraction method for measurement of non-metabolised peripheral benzodiazepine receptor ligands, [18F]PBR102 and [18F]PBR111, in rat and primate plasma. | Katsifis, A; Loc'h, C; Henderson, D; Bourdier, T; Pham, T; Greguric, I; Lam, P; Callaghan, P; Mattner, F; Eberl, S; Fulham, M |
| 1-Dec-2010 | Tumour response to gefitinib is associated with EGF- and gefitinib- but not radiation-modulated EGFR expression. | Lin, HQ; Katsifis, A; Meriaty, H |
Showing results 1 to 16 of 16
|
